Shijiazhuang Yiling Pharmaceutical Co., Ltd. is a national key high-tech enterprise founded by Wu Yiling, an academician of China Academy of Engineering. Under his leadership, Yiling Pharmaceutical has always adhered to the scientific and technological innovation development strategy with science and technology as the guide and market as the leading factor, established a unique operation mode of "theory-clinic-scientific research-industry-teaching", and established an innovative technology system for new drug research and development oriented to the theoretical innovation of collateral diseases in traditional Chinese medicine.
Yiling Pharmaceutical promotes the industrialization of traditional Chinese medicine with the innovation of collateral disease theory, and uses modern high-tech to research and develop scientific and technological traditional Chinese medicine, western medicine and biological medicine. We have developed more than 0/0 items of Chinese medicine with national patents, obtained more than 620 invention patents at home and abroad, and won more than 30 national, provincial and ministerial-level scientific and technological awards such as the first prize of national scientific and technological progress, the second prize of national scientific and technological progress and the second prize of national technological invention. Its products cover cardiovascular and cerebrovascular diseases, colds and respiratory diseases, tumors and diabetes.
The production bases built by the company in Shijiazhuang, Daxing, Miyun and other places in Hebei Province have created a perfect production layout, ensured the supply of products, introduced advanced equipment and pharmaceutical technology at home and abroad, created a total quality control system in line with international standards, ensured the safety of consumers' medication, established a strong marketing network and academic marketing team, and formed three business segments: scientific Chinese medicine, biochemical medicine and health industry. Its influence in the pharmaceutical industry continues to grow, and it has become one of the top 20 pharmaceutical listed companies.
On February, 2020 1 1, under the call of Hebei provincial government research office and Hebei pharmaceutical industry association, Yiling Pharmaceutical once again donated 8,000 boxes of Lianhua Qingwen capsules to Xianning City, Hubei Province, an epidemic area, to support the prevention and control of pneumonia in novel coronavirus.